Your browser doesn't support javascript.
loading
Down-regulation of A3AR signaling by IL-6-induced GRK2 activation contributes to Th17 cell differentiation.
Hu, Shanshan; Guo, Paipai; Wang, Zhen; Zhou, Zhengwei; Wang, Rui; Zhang, Mei; Tao, Juan; Tai, Yu; Zhou, Weijie; Wei, Wei; Wang, Qingtong.
Afiliação
  • Hu S; Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Collaborative Innovation Center of Anti-inflammatory and Immune Medicines, Hefei, Anhui, 230032, China; Anhui No.2 Provincial People's Hospital, Hefei, Anhui,
  • Guo P; Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Collaborative Innovation Center of Anti-inflammatory and Immune Medicines, Hefei, Anhui, 230032, China.
  • Wang Z; Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Collaborative Innovation Center of Anti-inflammatory and Immune Medicines, Hefei, Anhui, 230032, China.
  • Zhou Z; Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Collaborative Innovation Center of Anti-inflammatory and Immune Medicines, Hefei, Anhui, 230032, China.
  • Wang R; Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Collaborative Innovation Center of Anti-inflammatory and Immune Medicines, Hefei, Anhui, 230032, China.
  • Zhang M; Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Collaborative Innovation Center of Anti-inflammatory and Immune Medicines, Hefei, Anhui, 230032, China.
  • Tao J; Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Collaborative Innovation Center of Anti-inflammatory and Immune Medicines, Hefei, Anhui, 230032, China.
  • Tai Y; Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Collaborative Innovation Center of Anti-inflammatory and Immune Medicines, Hefei, Anhui, 230032, China.
  • Zhou W; Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Collaborative Innovation Center of Anti-inflammatory and Immune Medicines, Hefei, Anhui, 230032, China.
  • Wei W; Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Collaborative Innovation Center of Anti-inflammatory and Immune Medicines, Hefei, Anhui, 230032, China. Electronic address: wwei@ahmu.edu.cn.
  • Wang Q; Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Collaborative Innovation Center of Anti-inflammatory and Immune Medicines, Hefei, Anhui, 230032, China. Electronic address: hfwqt727@163.com.
Exp Cell Res ; 399(2): 112482, 2021 02 15.
Article em En | MEDLINE | ID: mdl-33434531

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-6 / Receptor A3 de Adenosina / Quinase 2 de Receptor Acoplado a Proteína G / Células Th17 Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Exp Cell Res Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-6 / Receptor A3 de Adenosina / Quinase 2 de Receptor Acoplado a Proteína G / Células Th17 Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Exp Cell Res Ano de publicação: 2021 Tipo de documento: Article